Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220389
Status:
COMPLETED
Last Update Posted:
2008-10-16
First Post:
2005-09-14
Brief Title:
Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder a Double-Blind Phase Followed by an Open-Label Extension Phase
Sponsor:
Organization:
Pfizer